Background: Given the mortality risk in COVID-19 patients, it is necessary to estimate the impact of glycemic control on mortality rates among inpatients by designing and implementing evidence-based blood glucose (BG) control methods. There is evidence to suggest that COVID-19 patients with hyperglycemia are at risk of mortality, and glycemic control may improve outcomes. However, the optimal target range of blood glucose levels in critically ill COVID-19 patients remains unclear, and further research is needed to establish the most effective glycemic control strategies in this population. Methods: The investigation was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Data sources were drawn from Google Scholar, ResearchGate, PubMed (MEDLINE), Cochrane Library, and Embase databases. Randomized controlled trials, non-randomized controlled trials, retrospective cohort studies, and observational studies with comparison groups specific to tight glycemic control in COVID-19 patients with and without diabetes. Results: Eleven observational studies (26,953 patients hospitalized for COVID-19) were included. The incidence of death was significantly higher among COVID-19 patients diagnosed with diabetes than those without diabetes (OR = 2.70 [2.11, 3.45] at a 95% confidence interval). Incidences of death (OR of 3.76 (3.00, 4.72) at a 95% confidence interval) and complications (OR of 0.88 [0.76, 1.02] at a 95% confidence interval) were also significantly higher for COVID-19 patients with poor glycemic control. Conclusion: These findings suggest that poor glycemic control in critically ill patients leads to an increased mortality rate, infection rate, mechanical ventilation, and prolonged hospitalization.
Background: Point-of-care ultrasound (POCUS) has become increasingly utilized as an important tool in acute care settings. Deliberate practice as part of POCUS training has previously been shown to enhance learner performance in image interpretation, though its efficacy in residents’ identification of hydronephrosis with renal POCUS has not been well-studied. In our study, we aimed to evaluate the learning curve for internal medicine residents using deliberate practice for the identification of hydronephrosis on renal POCUS interpretation. Methods: We recruited internal medicine residents from Mount Sinai Beth Israel and Mount Sinai Morningside/West, and asked them to complete a 30-case educational instrument on the interpretation of hydronephrosis. The study was conducted as a series of two separate hour-long sessions and included residents with varying baseline POCUS experience. We mapped cumulative accuracy as learning curves to assess resident performance. Results: A total of 47 participants completed the survey and deliberate practice instrument and demonstrated significant improvement in confidence level and image interpretation skills. All learners demonstrated improvement in accuracy with repetitive practice. We mapped the learning curve and found a plateau in accuracy at 20–25 cases. Statistical analysis of the results was performed with Microsoft Excel Version 16.85, and R version 4.3.2. Conclusion: Deliberate practice in the identification of hydronephrosis on renal POCUS using a novel case-based instrument improves residents’ accuracy. This approach is easily reproducible, can impact learners at different stages of experience, and can be integrated into a more comprehensive curriculum on POCUS.
Lung cancer remains the leading cause of cancer-related mortality worldwide, with late-stage diagnosis contributing to poor prognosis. Incidental lung nodu